v3.26.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 12 Months Ended
Mar. 31, 2026
Intangible Asset, Goodwill and Other [Abstract]  
SCHEDULE OF GOODWILL

The following table summarizes the goodwill activity for the year ended March 31, 2026:

 

   Orocidin   Bio-Convert   Total 
Balance as of March 31, 2025  $7,084,829   $18,405,922   $25,490,751 
Foreign currency translation adjustment   464,225    1,206,024    1,670,249 
Balance as of March 31, 2026  $7,549,054   $19,611,946   $27,161,000 
SCHEDULE OF IN-PROCESS RESEARCH AND DEVELOPMENT ACTIVITY

The following table summarizes the in-process research and development activity for the year ended March 31, 2026:

 

   Orocidin   Bio-Convert   Total 
Balance as of March 31, 2025  $15,679,626   $27,028,453   $42,708,079 
Foreign currency translation adjustment   1,027,387    1,771,005    2,798,392 
Balance as of March 31, 2026  $16,707,013   $28,799,458   $45,506,471